Desmopressin in the Management of Nocturia in Patients With Multiple Sclerosis

1996100 citationsJournal Article

Authors

Guy Valiquette · Multiple Sclerosis Center Of Northeastern New York

Abstract

Desmopressin was found effective; no tolerance and only minimal adverse effects have been observed. Our results suggest that desmopressin, either alone or in combination with other therapeutic modalities, is effective in the symptomatic management of nocturia in patients with MS. The only adverse effect attributed to desmopressin was hyponatremia, which occurred in 4 of 17 patients and appeared to be dose related.

Topics & Keywords

Multiple Sclerosis Research Studies Pathogenesis and Treatment of Hiccups Polyomavirus and related diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Neurology

Volume 53, Issue 12, pp. 1270-1270

DOI: 10.1001/archneur.1996.00550120082020

Field-Weighted Citation Impact: 3.93